These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 34356308)

  • 1. Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism.
    Tang G; Xu Y; Zhang C; Wang N; Li H; Feng Y
    Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.
    Xiao J; Ho CT; Liong EC; Nanji AA; Leung TM; Lau TY; Fung ML; Tipoe GL
    Eur J Nutr; 2014 Feb; 53(1):187-99. PubMed ID: 23515587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease.
    Chen C; Liu Q; Liu L; Hu YY; Feng Q
    Mol Nutr Food Res; 2018 Jan; 62(1):. PubMed ID: 28799714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21-AMPK pathway in mice fed a high fat diet.
    Zhang Y; Yin R; Lang J; Fu Y; Yang L; Zhao D
    Diabetol Metab Syndr; 2022 Apr; 14(1):53. PubMed ID: 35418153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis.
    Ding SB; Chu XL; Jin YX; Jiang JJ; Zhao X; Yu M
    Front Pharmacol; 2023; 14():1148814. PubMed ID: 37025486
    [No Abstract]   [Full Text] [Related]  

  • 6. Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation.
    Zuo G; Chen M; Zuo Y; Liu F; Yang Y; Li J; Zhou X; Li M; Huang JA; Liu Z; Lin Y
    J Agric Food Chem; 2024 Apr; ():. PubMed ID: 38607257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats.
    Hou H; Yang W; Bao S; Cao Y
    J Oleo Sci; 2020 May; 69(5):479-486. PubMed ID: 32281563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4.
    Yang M; Yan R; Sha R; Wang X; Zhou S; Li B; Zheng Q; Cao Y
    Clin Nutr; 2024 Aug; 43(8):1769-1780. PubMed ID: 38936303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota.
    Dey P; Olmstead BD; Sasaki GY; Vodovotz Y; Yu Z; Bruno RS
    J Nutr Biochem; 2020 Oct; 84():108455. PubMed ID: 32688217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
    Santamarina AB; Carvalho-Silva M; Gomes LM; Okuda MH; Santana AA; Streck EL; Seelaender M; do Nascimento CM; Ribeiro EB; Lira FS; Oyama LM
    J Nutr Biochem; 2015 Nov; 26(11):1348-56. PubMed ID: 26300331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease.
    Zhou J; Ho CT; Long P; Meng Q; Zhang L; Wan X
    J Agric Food Chem; 2019 May; 67(19):5306-5317. PubMed ID: 30892882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salubrious Effects of Green Tea Catechins on Fatty Liver Disease: A Systematic Review.
    Abunofal O; Mohan C
    Medicines (Basel); 2022 Mar; 9(3):. PubMed ID: 35323719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data.
    Hidalgo I; Ortiz-Flores M; Villarreal F; Fonseca-Coronado S; Ceballos G; Meaney E; Nájera N
    J Basic Clin Physiol Pharmacol; 2022 Nov; 33(6):703-714. PubMed ID: 35119232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hesperetin ameliorates hepatic oxidative stress and inflammation
    Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
    Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of green tea in nonalcoholic fatty liver disease.
    Masterjohn C; Bruno RS
    Nutr Rev; 2012 Jan; 70(1):41-56. PubMed ID: 22221215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin-3-gallate suppresses cigarette smoke-induced inflammation in human cardiomyocytes via ROS-mediated MAPK and NF-κB pathways.
    Liang Y; Ip MSM; Mak JCW
    Phytomedicine; 2019 May; 58():152768. PubMed ID: 31005721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
    Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
    Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats.
    Yang Z; Zhu MZ; Zhang YB; Wen BB; An HM; Ou XC; Xiong YF; Lin HY; Liu ZH; Huang JA
    Phytother Res; 2019 Apr; 33(4):1019-1026. PubMed ID: 30746789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin-3-gallate and hydroxytyrosol improved antioxidative and anti-inflammatory responses in bovine mammary epithelial cells.
    Basiricò L; Morera P; Dipasquale D; Bernini R; Santi L; Romani A; Lacetera N; Bernabucci U
    Animal; 2019 Dec; 13(12):2847-2856. PubMed ID: 31182175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.